Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 1076 - 1100 of 1564 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▲ Formula
Gangliosides LMSP0601FO08
  • NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44263059 2224.197785 C103H181N5O46
Gangliosides LMSP0601GP08
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44263243 2224.197785 C103H181N5O46
Gangliosides LMSP0601GX08
  • NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6(GalNAcbeta1-3Galalpha1-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44263307 2224.197785 C103H181N5O46
Gangliosides LMSP0601BL04
  • 9-O-acetyl GTb1(d18:1/22:0)
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(9-OAc-NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262263 2226.140665 C101H175N5O48
Gangliosides LMSP0601BW07
  • GT1b(d18:1/24:1(15Z))
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262354 2226.140665 C101H175N5O48
Gangliosides LMSP0601CF07
  • GT1ba(d18:1/24:1(15Z))
  • Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262418 2226.140665 C101H175N5O48
Gangliosides LMSP0601DR06
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262689 2226.213435 C103H183N5O46
Gangliosides LMSP0601EY06
  • NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262937 2226.213435 C103H183N5O46
Gangliosides LMSP0601FO06
  • NeuAcalpha2-3Galbeta1-4GlcNAcalpha1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44263057 2226.213435 C103H183N5O46
Gangliosides LMSP0601GP06
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44263241 2226.213435 C103H183N5O46
Gangliosides LMSP0601GX06
  • NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6(GalNAcbeta1-3Galalpha1-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44263305 2226.213435 C103H183N5O46
Gangliosides LMSP0601CM07
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262466 2227.161066 C102H178N4O48
Gangliosides LMSP0601BW05
  • GT1b(d18:1/24:0)
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262352 2228.156315 C101H177N5O48
Gangliosides LMSP0601CF05
  • GT1ba(d18:1/24:0)
  • Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262416 2228.156315 C101H177N5O48
Gangliosides LMSP0601CM05
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262464 2229.176716 C102H180N4O48
Gangliosides LMSP0601GB03
  • NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44263142 2230.13558 C100H175N5O49
Gangliosides LMSP0601DO03
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • sLea -Lex(d18:1/20:0)
44262662 2231.155981 C101H178N4O49
Gangliosides LMSP0601EN03
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • sLea-x(d18:1/20:0)
44262854 2231.155981 C101H178N4O49
Gangliosides LMSP0601EW03
  • NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • sialyl dimeric Lex(d18:1/20:0)
44262918 2231.155981 C101H178N4O49
Gangliosides LMSP0601BQ02
  • NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262301 2234.09411 C98H171N5O51
Gangliosides LMSP0601AR08
  • GT1c(d18:1/26:1(17Z))
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262107 2238.17705 C103H179N5O47
Gangliosides LMSP0601AT08
  • GT1b(d18:1/26:1(17Z))
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262123 2238.17705 C103H179N5O47
Gangliosides LMSP0601AW08
  • GT1a(d18:1/26:1(17Z))
  • NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262147 2238.17705 C103H179N5O47
Gangliosides LMSP0601BF08
  • GT1aa(d18:1/26:1(17Z))
  • NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262219 2238.17705 C103H179N5O47
Gangliosides LMSP0601CS08
  • NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262515 2238.17705 C103H179N5O47

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024